Finite mixture regression model analysis on antipsychotics induced weight gain: Investigation of the role of the serotonergic genes

European Neuropsychopharmacology

Volumn 23, Issue 3, 2013, Pages 224-228

  Nowrouzi, Behdin ^a   Souza, Renan P ^b   Zai, Clement ^b   Shinkai, Takahiro ^g   Monda, Marcellino ^h   Lieberman, Jeffrey ^e   Volvaka, Jan ^f   Meltzer, Herbert Y ^d   Kennedy, James L ^b,c   De Luca, Vincenzo ^b,c  

^a LAURENTIAN UNIVERSITY   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d NORTHWESTERN UNIVERSITY   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^g UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^h SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Antipsychotics; FMM; Genetics; Schizophrenia; Serotonin; Weight gain

Indexed keywords

CLOZAPINE; HALOPERIDOL; OLANZAPINE; RISPERIDONE; SEROTONIN RECEPTOR;

ADULT; ARTICLE; COVARIANCE; DNA POLYMORPHISM; ETHNICITY; FEMALE; FINITE ELEMENT ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; SIDE EFFECT; WEIGHT GAIN;

ADULT; AFRICAN AMERICANS; ANTIPSYCHOTIC AGENTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, SEROTONIN; REGRESSION ANALYSIS; RISK; SCHIZOPHRENIA; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRYPTOPHAN HYDROXYLASE; WEIGHT GAIN;

EID: 84875247155     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2012.05.008     Document Type: Article

References (18)

1. Allison D.B., Mackell J.A., McDonnell D.D. The impact of weight gain on quality of life among persons with schizophrenia. Psychiatr. Serv. 2003, 54(4):565-567.
2. Basile V.S., Masellis M., McIntyre R.S., Meltzer H.Y., Lieberman J.A., Kennedy J.L. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle. J. Clin. Psychiatry 2001.
3. Basile V.S., Masellis M., Potkin S.G., Kennedy J.L. Pharmacogenomics in schizophrenia: the quest for individualized therapy. Hum. Mol. Genet. 2002, 11(20):2517.
4. Blin O., Micallef J. Antipsychotic-associated weight gain and clinical outcome parameters. J. Clin. Psychiatry 2001.
5. Deb P. FMM: stata module to estimate finite mixture models (version 11). Statistical Software Components S456895 2007, Boston College Department of Economics, Boston, MA, (5 pp).
6. Deb P., Gallo W.T., Ayyagari P., Fletcher J.M., Sindelar J.L. The effect of job loss on overweight and drinking. J. Health Econ 2011.
7. Haddad P.M. Antipsychotics and diabetes: review of non-prospective data. Br. J. Psychiatry 2004, 184(47):s80-s86.
8. Heckman J., Singer B. A method for minimizing the impact of distributional assumptions in econometric models for duration data. Econometrica: J. Econometric Soc. 1984, 271-320.
9. Lahiri D.K., Nurnberger J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991, 19(19):5444.
10. Laird N. Nonparametric maximum likelihood estimation of a mixing distribution. J. Am. Stat. Assoc. 1978, 805-811.
11. Le Hellard S., Theisen F., Haberhausen M., Raeder M., Fernø J., Gebhardt S., Mehler-Wex C. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects quest. Mol. Psychiatry 2008, 14(3):308-317.
12. Lindsay, B., 1995. Mixture Models: Theory, Geometry, and Applications, 5 of NSF-CBMS Regional Conference Series in Probability and Statistics. Institute for Mathematical Statistics, Hayward, CA.
13. Newcomer J.W. Antipsychotic medication-induced weight gain and risk for diabetes and cardiovascular disease. Energy Metab. Obesity 2008, 223-245.
14. Ogden C.L., Yanovski S.Z., Carroll M.D., Flegal K.M. The epidemiology of obesity. Gastroenterology 2007, 132(6):2087-2102.
15. The Office of Minority Health, 2011, January 25. Obesity and African Americans. (retrieved 23.05.2012). http://minorityhealth.hhs.gov/templates/content.aspx?ID=6456.
16. Theisen F.M., Gebhardt S., Haberhausen M., Heinzel-Gutenbrunner M., Wehmeier P.M., Krieg J.C., Hebebrand J. Clozapine-induced weight gain: a study in monozygotic twins and same-sex sib pairs. Psychiatr. Genet. 2005, 15(4):285.
17. Wetterling T. Bodyweight gain with atypical antipsychotics: a comparative review. Drug Saf. 2001, 24(1):59-74.
18. Yanovski S.Z., Yanovski J.A. Obesity. N. Engl. J. Med. 2002, 346(8):591-602. 10.1056/NEJMra012586.